A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy Article Proceedings Paper

authors

publication date

  • April 1, 2007

webpage

published in

start page

  • 896

end page

  • 902

volume

  • 30

issue

  • 4